These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 19651630

  • 1. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
    Luan F, Liu H, Gao L, Liu J, Sun Z, Ju Y, Hou N, Guo C, Liang X, Zhang L, Sun W, Ma C.
    Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
    [Abstract] [Full Text] [Related]

  • 2. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
    Liu H, Luan F, Ju Y, Shen H, Gao L, Wang X, Liu S, Zhang L, Sun W, Ma C.
    Biochem Biophys Res Commun; 2007 Apr 06; 355(2):379-84. PubMed ID: 17307151
    [Abstract] [Full Text] [Related]

  • 3. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells.
    Zhang X, Dong N, Zhang H, You J, Wang H, Ye L.
    J Lab Clin Med; 2005 Feb 06; 145(2):98-104. PubMed ID: 15746653
    [Abstract] [Full Text] [Related]

  • 4. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
    Zhang X, Gao L, Liang X, Guo M, Wang R, Pan Y, Liu P, Zhang F, Guo C, Zhu F, Qu C, Ma C.
    Liver Int; 2015 Mar 06; 35(3):1087-94. PubMed ID: 25047684
    [Abstract] [Full Text] [Related]

  • 5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP.
    Eur J Cancer Prev; 2008 Jun 06; 17(3):209-17. PubMed ID: 18414191
    [Abstract] [Full Text] [Related]

  • 6. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
    Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A.
    Liver Int; 2009 Sep 06; 29(8):1162-70. PubMed ID: 19627485
    [Abstract] [Full Text] [Related]

  • 7. Effect of preS2 antisense RNA on hepatocellular carcinoma with a novel delivery system.
    Ma C, Sun W, Tian P, Wang X, Liu S, Zhang L, Cao Y, Zhu F, Zhang Q.
    Chin Med J (Engl); 2003 May 06; 116(5):717-20. PubMed ID: 12875688
    [Abstract] [Full Text] [Related]

  • 8. RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity.
    Zhang PH, Zou L, Tu ZG.
    J Surg Res; 2006 Mar 06; 131(1):143-9. PubMed ID: 16298398
    [Abstract] [Full Text] [Related]

  • 9. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma.
    Takuma Y, Nouso K, Kobayashi Y, Nakamura S, Tanaka H, Matsumoto E, Fujikawa T, Suzuki M, Hanafusa T, Shiratori Y.
    J Gastroenterol Hepatol; 2004 Nov 06; 19(11):1300-4. PubMed ID: 15482538
    [Abstract] [Full Text] [Related]

  • 10. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
    Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL.
    Ai Zheng; 2004 Jun 06; 23(6):619-25. PubMed ID: 15191658
    [Abstract] [Full Text] [Related]

  • 11. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis.
    Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C.
    Am J Gastroenterol; 2006 Apr 06; 101(4):831-8. PubMed ID: 16494581
    [Abstract] [Full Text] [Related]

  • 12. Telomerase and c-myc expression in hepatocellular carcinomas.
    Liu YC, Chen CJ, Wu HS, Chan DC, Yu JC, Yang AH, Cheng YL, Lee SC, Harn HJ.
    Eur J Surg Oncol; 2004 May 06; 30(4):384-90. PubMed ID: 15063891
    [Abstract] [Full Text] [Related]

  • 13. Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.
    Gai X, Zhao P, Pan Y, Shan H, Yue X, Du J, Zhang Z, Liu P, Ma H, Guo M, Yang X, Sun W, Gao L, Ma C, Liang X.
    Int J Biochem Cell Biol; 2013 Jul 06; 45(7):1174-85. PubMed ID: 23542016
    [Abstract] [Full Text] [Related]

  • 14. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ, Li C, Zhou XJ, Guan HG, Qin L, Li P, Wang ZW, Qian HX.
    J Gastroenterol Hepatol; 2008 Sep 06; 23(9):1448-58. PubMed ID: 17683489
    [Abstract] [Full Text] [Related]

  • 15. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
    Liu P, Zhang H, Liang X, Ma H, Luan F, Wang B, Bai F, Gao L, Ma C.
    Oncotarget; 2015 Oct 06; 6(30):29048-59. PubMed ID: 26315112
    [Abstract] [Full Text] [Related]

  • 16. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma.
    Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K, Tsuji T.
    Br J Cancer; 2000 Feb 06; 82(4):833-7. PubMed ID: 10732755
    [Abstract] [Full Text] [Related]

  • 17. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M, Gatselis N, Iliopoulos D, Zacharoulis D, Dalekos GN, Tsezou A.
    J Viral Hepat; 2007 Jan 06; 14(1):41-7. PubMed ID: 17212643
    [Abstract] [Full Text] [Related]

  • 18. [Expression of human telomerase reverse transcriptase gene in HCC does not depend on proliferating cell nuclear antigen and P53].
    Zhang D, Li KZ, Dou KF, Gao ZQ, Song ZS, Zhao QC, Fu YC.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Nov 06; 20(6):721-2. PubMed ID: 15555445
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma.
    Mizukoshi E, Nakamoto Y, Marukawa Y, Arai K, Yamashita T, Tsuji H, Kuzushima K, Takiguchi M, Kaneko S.
    Hepatology; 2006 Jun 06; 43(6):1284-94. PubMed ID: 16729333
    [Abstract] [Full Text] [Related]

  • 20. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U, Amann T, Winklmeier A, Braig S, Schubert T, Weiss TS, Schardt K, Warnecke C, Hellerbrand C, Bosserhoff AK.
    J Pathol; 2009 Aug 06; 218(4):520-9. PubMed ID: 19431154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.